8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Sep 19, 2023 · 2y ago · Accession 0001193125-23-237644
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- 8-K
- Filing date
- Sep 19, 2023
- Report date
- Sep 19, 2023
- Document
- d541406d8k.htm
- Size
- 428 KB